FDA Investigator: Katherine E. Jacobitz

- Katherine E. Jacobitz first started conducting FDA inspections in 2000, with the last inspection in 2022. Over that time, Katherine E. Jacobitz has conducted 106 inspections at 95 companies across 99 sites.

Get Katherine Jacobitz's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Laboratoires Clarins, Pontoise | 2022

Out-of-stock
Katherine E. Jacobitz
Human Drugs Form 483

FDA 483 Roche Singapore Technical Operations Pte. Ltd., Singapore | 2022

Out-of-stock
Katherine E. Jacobitz
Human Drug Form 483

FDA 483 Ajinomoto Althea, Inc., San Diego | 2017

Out-of-stock
Katherine E. Jacobitz
Human Drug Form 483

FDA 483 GP Pharm SA, Sant Quinti De Mediona | 2017

Out-of-stock
Katherine E. Jacobitz
Human Drug Form 483

FDA 483 Blue Cross Laboratories, Inc, Santa Clarita | 2015

Out-of-stock
Katherine E. Jacobitz
Human Drug Form 483

FDA 483 Shadow Holdings, LLC, Santa Clarita | 2015

Out-of-stock
Katherine E. Jacobitz
Human Drug Form 483

FDA 483 Unilever Manufacturing (US), Inc., Jonesboro | 2015

Out-of-stock
Katherine E. Jacobitz
Human Drug Form 483

FDA 483 Fresenius Kabi Austria Gmbh, Graz | 2015

Out-of-stock
Katherine E. Jacobitz
Human Drug Form 483

FDA 483 Pierre Fabre Medicament Production, Idron | 2015

Out-of-stock
Katherine E. Jacobitz
Human Drug Form 483

FDA 483 Southwest Products, LLC, San Diego | 2014

Out-of-stock
Katherine E. Jacobitz
Foods & Cosmetic Form 483

FDA 483 Beckman Coulter, Inc., Carlsbad | 2011

Out-of-stock
Katherine E. Jacobitz
Medical Devices & Rad Health Form 483

Co-Investigators (61)